Showing 2642 results
- Media Library /
- Media Release /At least 24 million doses of the mRNA-based vaccine will be filled in 2022 into vials under sterile conditions at Novartis Technical Operations state-of-the-art facility in Ljubljana, Slovenia New…
- Featured News /
- Key Release /Ad hoc announcement pursuant to Art. 53 LR CANOPY-1 Phase III study did not meet its primary endpoints of overall survival (OS) and progression-free survival (PFS)…
- Story /
Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.
Pagination
- ‹ Previous page
- 1
- …
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- …
- 265
- › Next page